2Dokal I, Vulliamy T. Inherited aplaslic anaemias/5one marrow failure syndromes. Blood Rev, 2008,22:141.
3Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood,2006, 108:2509.
4Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anaemia; a prospective study of the effect of early marrow trans- plantation on acute mortality. Blood,1976, 48:63.
5Brodsky RA, Jones RJ. Aplastic anaemia. Lancet, 2005, 365: 1647.
6Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occuring after treatment of aplastic anemia. N Engl J Med, 1993,329:1152.
7Kahl C, Leisenring W, Deeg HJ et al. Cyclophosphamide and antithymocyteglobulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anemia: a long-termfollow up. Br J Haematol, 2005,130: 747.
8Champlin RE, Perez WS, Passweg JR et al. Bone marrow trans plantation for severe aplastic anemia: a randomized, controlled study of condition ing regimens. Blood, 2007,109: 4582.
9Locasciulli A, Oneto R, Bacigalupo A et al. Outcome of patients with acquired ap]astic anemia given first line bone marrow trans plantation or immunosuppressive treatment in the last decade :a report from the European Group for Blood and Marrow Trans- plantation (EBMT). Haematologica, 2007,92 : 11.
10Gupta V, Eapen M, Brazauskas R,et al. Impact of age on outcomes alter bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors. Haematologica, 2010,95:2119.
